June 10, 2021 AI4C: Global regulation of AI - what you need to know
An overview of the European MDR and FDA pathways for regulating AI software as a medical device. Focus on the new changes to the new MDR since May 2021. Discussion of the FDAs proposed pathway for good machine learning practice.
This lecture series in intended for Physicians of all specialties, nurses, Physician Assistants, Information Technology Specialists, and Researchers interested in Artificial Intelligence in healthcare. Faculty of all levels, students, residents, and fellows welcome. Personnel from the healthcare technology sector may also be interested in attending the series.
Upon completion of this activity, participants will be able to:
- Describe Artificial Intelligence (AI) and Machine Learning (ML) at a high-level.
- Identify current limitations of AI in healthcare.
- Cite examples of AI as applied to imaging and other healthcare data.
- Describe example AI tools that can impact workflow in the healthcare arena.
- Utilize clinical AI applications appropriately.
Massachusetts General Hospital and Brigham & Women's Hospital, Center for Clinical Data Science & Mass General Brigham
Katherine P. Andriole, PhD., FSIIM
Director of Research, Strategy and Operations
MGH & BWH Center for Clinical Data Science
Associate Professor of Radiology
Brigham and Women’s Hospital
Harvard Medical School
Hugh Harvey, MBBS BSc(Hons) FRCR MD(Res) FBIR
Managing Director | Hardian Health
Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ per session. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation